Marta Schirripa
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Pathology and Forensic Medicine top 2%
- Molecular Biology
- Hepatology top 2%
- Co-authors
- Fotios LoupakisChiara CremoliniAlfredo FalconeLisa SalvatoreGianluca MasiSara LonardiHeinz‐Josef LenzFrancesca Bergamo
- Topics
- Colorectal Cancer Treatments and Studies (94 papers)Cancer Treatment and Pharmacology (30 papers)Lung Cancer Treatments and Mutations (29 papers)
- Partner nations
- ItalyUnited StatesJapan
In The Last Decade
Marta Schirripa
117 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 85
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 538
- Pathology and Forensic Medicine 494
- Molecular Biology 489
- Hepatology 404
Countries citing papers authored by Marta Schirripa
This map shows the geographic impact of Marta Schirripa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Schirripa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Schirripa more than expected).
Fields of papers citing papers by Marta Schirripa
This network shows the impact of papers produced by Marta Schirripa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Schirripa. The network helps show where Marta Schirripa may publish in the future.
Co-authorship network of co-authors of Marta Schirripa
This figure shows the co-authorship network connecting the top 25 collaborators of Marta Schirripa. A scholar is included among the top collaborators of Marta Schirripa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Schirripa. Marta Schirripa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | 6 | |
| 10 | 20 | |
| 11 | 76 | |
| 12 | 5 | |
| 13 | 11 | |
| 14 | 44 | |
| 15 | 8 | |
| 16 | 21 | |
| 17 | 29 | |
| 18 | 1 | |
| 19 | Folfoxiri plus Bevacizumab as first-line treatment of BRAF mutant metastatic colorectal cancer patients. | 4 |
| 20 | 58 |
About Marta Schirripa
Marta Schirripa is a scholar working on Oncology, Cancer Research and Hepatology, having authored 125 papers that have together received 1.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (94 papers), Cancer Treatment and Pharmacology (30 papers) and Lung Cancer Treatments and Mutations (29 papers). The work is most often cited by research in Oncology (1.4k citations), Hepatology (404 citations) and Pathology and Forensic Medicine (494 citations). Marta Schirripa has collaborated with scholars based in Italy, United States and Japan. Frequent co-authors include Fotios Loupakis, Chiara Cremolini, Alfredo Falcone, Lisa Salvatore, Gianluca Masi, Sara Lonardi, Heinz‐Josef Lenz, Francesca Bergamo, Carlotta Antoniotti and Vittorina Zagonel. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.